Clinical Trials Logo

Urethritis clinical trials

View clinical trials related to Urethritis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05564299 Recruiting - Clinical trials for Sexually Transmitted Infections

Rapid Diagnostic Assay for Gonorrhea and Chlamydia

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

This study is a pilot randomized controlled trial evaluating the use of either a) rapid 30-minute desktop assay or b) point-of-care gram stain (current standard of care) to guide the clinical management of patients with symptomatic urethritis or cervicitis evaluated in the Massachusetts General Hospital Sexual Health Clinic. Patients presenting with symptoms of urethritis or cervicitis and meeting inclusion criteria will be randomized to have diagnostic specimens tested during the clinical encounter using either the 30-minute desktop assay or point-of-care gram stain. Patients randomized to the intervention arm of the study will also have a gram stain created, which will be held for interpretation by the clinician following the clinical encounter. Patients will not be followed longitudinally. Recruitment will conclude when 100 participants enroll in the study.

NCT ID: NCT05399173 Recruiting - Clinical trials for Non-Specific Urethritis

Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of laser acupuncture on monosymptomatic nocturnal enuresis in adolescent females.

NCT ID: NCT01661985 Recruiting - Clinical trials for Chlamydia Trachomatis

Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

Start date: February 2010
Phase: Phase 4
Study type: Interventional

The purpose of this on-going study is to study the number of days after antibiotic treatment has commenced (due to infection caused by the sexually transmitted bacteria Chlamydia trachomatis (CT) and Mycoplasma genitalium(Mg)) it takes to be cured i.e to get a negative test result. The specimens are analyzed on first-catch-urine (men) or patient's self-obtained vaginal sample with quantitive nucleic acid amplification test(NAAT). A secondary aim is to detect macrolide resistant Mg-strains and study whether there are any emerging macrolide resistant Mg-strains after treatment with azithromycin. A third aim is to study whether the participating subjects are adherent to the study protocol meaning 12 samples taken during a period of four weeks.